Abstract
Purpose
This study was designed to describe the clinical, laboratorial, and urodynamic findings of prostatic artery embolization (PAE) in patients with urinary retention due to benign prostatic hyperplasia (BPH).
Methods
A prospective study of 11 patients with urinary retention due to BPH was conducted. Patients underwent physical examination, prostate specific antigen (PSA) measurement, transrectal ultrasound, and magnetic resonance imaging. International prostate symptom score (IPSS), quality of life (QoL), and urodynamic testing were used to assess the outcome before and after 1 year.
Results
Clinical success was 91 % (10/11 patients) with a mean follow-up of 22.3 months (range, 12–41 months). At the first year follow-up, the mean IPSS score was 2.8 points (p = 0.04), mean QoL was 0.4 points (p = 0.001), mean PSA decreased from 10.1 to 4.3 ng/mL (p = 0.003), maximum urinary flow (Qmax) improved from 4.2 to 10.8 mL/sec (p = 0.009), and detrusor pressure (Pdet) decreased from 85.7 to 51.5 cm H2O (p = 0.007). Before PAE, Bladder Outlet Obstruction Index (BOOI) showed values >40 in 100 % of patients. After PAE, 30 % of patients were >40 (obstructed), 40 % were between 20 and 40 (undetermined), and 30 % were <20 (unobstructed). Patients with a BOOI <20 had higher PSA values at 1-day after PAE.
Conclusions
Clinical and urodynamic parameters improved significantly after PAE in patients with acute urinary retention due to BPH. Total PSA at day 1 after PAE was higher in patients with unobstructed values in pressure flow studies.
Similar content being viewed by others
References
McVary KT (2006) BPH: epidemiology and comorbidities. Am J Manage Care 12(5 Suppl):122–128
Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ (2004) EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46:547–554
McVary KT, Roehrborn CG, Avins AL et al (2011) Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 185(5):1793–1803
Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP): incidence, management, and prevention. Eur Urol 50(5):969–979
Mitchell ME, Waltman AC, Athanasoulis CA, Kerr WS Jr, Dretler SP (1976) Control of massive prostatic bleeding with angiographic techniques. J Urol 115(6):692–695
Bischoff W, Goerttler U (1977) Successful intra-arterial embolization of bleeding carcinoma of the prostate. Urologe A 16:99–102
Nadalini VF, Positano N, Bruttini GP, Medica M, Fasce L (1981) Therapeutic occlusion of the hypogastric arteries with isobutyl-2-cyanoacrylate in vesical and prostatic cancer. Radiol Med 67(1–2):61–66
Appleton DS, Sibley GN, Doyle PT (1988) Internal iliac artery embolisation for the control of severe bladder and prostate haemorrhage. Br J Urol 61(1):45–47
DeMeritt JS, Elmasri FF, Esposito MP, Rosemberg GS (2000) Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization. J Vasc Interv Radiol 11(6):767–770
Barbieri A, Simonazzi M, Marcato C et al (2002) Massive hematuria after transurethral resection of the prostate: management by intra-arterial embolization. Urol Int 69(4):318–320
Michel F, Dubruille T, Cercueil JP, Paparel P, Cognet F, Krause D (2002) Arterial embolization for massive hematuria following transurethral prostatectomy. J Urol 168(6):2550–2551
Rastinehad AR, Caplin DM, Ost MC et al (2008) Selective arterial prostatic embolization (SAPE) for refractory hematuria of prostatic origin. Urology 71(2):181–184
Tan L, Venkatesh SK, Consigliere D, Heng CT (2009) Treatment of a patient with post-TURP hemorrhage using bilateral SAPE. Nat Rev Urol 6(12):680–685
Sun F, Sánchez FM, Crisóstomo V et al (2008) Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment—preliminary study in pigs. Radiology 246(3):783–789
Jeon GS, Won JH, Lee BM et al (2009) The effect of transarterial prostate embolization in hormone-induced benign prostatic hyperplasia in dogs: a pilot study. J Vasc Interv Radiol 20(3):384–390
Carnevale FC, Antunes AA, da Motta-Leal-Filho JM et al (2010) Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol 33(2):355–361
Carnevale FC, da Motta-Leal-Filho JM, Antunes AA et al (2011) Midterm follow-up after prostate embolization in two patients with benign prostatic hyperplasia. Cardiovasc Intervent Radiol 34(6):1330–1333
Schäfer W, Abrams P, Liao L et al (2002) Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21:261–274
Abrams P (1999) Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int 84(1):14–15
Kuntz RM, Ahyai S, Lehrich K, Fayad A (2004) Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 172:1012–1016
Muzzonigro G, Milanese G, Minardi D, Yehia M, Galosi AB, Dellabella M (2004) Safety and efficacy of transurethral resection of prostate glands up to 150 mL: a prospective comparative study with 1 year of followup. J Urol 172:611–615
Pisco JM, Pinheiro LC, Bilhim T, Duarte M, Mendes JR, Oliveira AG (2011) Prostatic artery embolization to treat benign prostatic hyperplasia. J Vasc Interv Radiol 22(1):11–19
Carnevale FC, da Motta-Leal-Filho JM, Antunes AA et al (2013) Quality of life and clinical symptoms improvement support prostatic artery embolization for patients with acute urinary retention due to benign prostatic hyperplasia. J Vasc Interv Radiol. doi:10.1016/j.jvir.2012.12.019
Milord RA, Kahane H, Epstein JI (2000) Infarct of the prostate gland: experience on needle biopsy specimens. Am J Surg Pathol 24(10):1378–1384
Cross MJ, Claesson-Welsh L (2001) FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 22:201–207
Antunes AA, de Freire G C, Aiello Filho D, Cury J, Srougi M (2006) Analysis of the risk factors for incidental carcinoma of the prostate in patients with benign prostatic hyperplasia. Clinics (São Paulo) 61(6):545–550
Conflict of interest
Alberto Azoubel Antunes, Francisco Cesar Carnevale, Joaquim Mauricio da Motta-Leal-Filho, Eduardo Muracca Yoshinaga, Luciana Mendes de Oliveira Cerri, Ronaldo Hueb Baroni, Antonio Sergio Zafred Marcelino, Giovanni Guido Cerri, Miguel Srougi have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Antunes, A.A., Carnevale, F.C., da Motta Leal Filho, J.M. et al. Clinical, Laboratorial, and Urodynamic Findings of Prostatic Artery Embolization for the Treatment of Urinary Retention Related to Benign Prostatic Hyperplasia. A Prospective Single-Center Pilot Study. Cardiovasc Intervent Radiol 36, 978–986 (2013). https://doi.org/10.1007/s00270-013-0611-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-013-0611-5